How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review

Author(s):: Esdonk, M.J. van; Zutphen, E.J.M. van; Roelfsema, F.; Pereira, A.M.; Graaf, P.H. van der; Biermasz, N.R. (0000-0001-5817-3594); Stevens, J.; Burggraaf, J.

Published: 2018
Publication type: Article / Letter to editor

AcromegalyGrowth hormonePituitary adenomaIGF-1-review

Date issued: 2018-06-30
Language: English
Is part of: Pituitary (2018), Vol. 21, no. 3, p. 310-322
hdl: 1887/75538
doi: 10.1007/s11102-018-0884-4
URL: https://link.springer.com/content/pdf/10.1007/s11102-018-0884-4.pdf